Do Elevated YKL-40 Levels Drive the Immunosuppressive Tumor Microenvironment in Colorectal Cancer? Assessment of the Association of the Expression of YKL-40, MMP-8, IL17A, and PD-L1 with Coexisting Type 2 Diabetes, Obesity, and Active Smoking
The influence of chitinase-3-like protein 1 (YKL-40 or CHI3L1) expression on the immunological properties of the tumor microenvironment, which may affect the effectiveness of immunotherapy, is currently not sufficiently understood in colorectal cancer (CRC). The aim of this study was to investigate...
Main Authors: | Błażej Ochman, Sylwia Mielcarska, Agnieszka Kula, Miriam Dawidowicz, Julia Robotycka, Jerzy Piecuch, Monika Szrot, Sylwia Dzięgielewska-Gęsiak, Małgorzata Muc-Wierzgoń, Dariusz Waniczek, Elżbieta Świętochowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-03-01
|
Series: | Current Issues in Molecular Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/1467-3045/45/4/182 |
Similar Items
-
Prognosis and Reclassification by YKL‐40 in Stable Coronary Artery Disease
by: Jakob Schroder, et al.
Published: (2020-03-01) -
Plasma YKL-40 in the spectrum of neurodegenerative dementia
by: Anna Villar-Piqué, et al.
Published: (2019-07-01) -
YKL-40—A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?
by: Julia S. Johansen, et al.
Published: (2010-07-01) -
Selection and Characterization of YKL-40-Targeting Monoclonal Antibodies from Human Synthetic Fab Phage Display Libraries
by: Kyungjae Kang, et al.
Published: (2020-09-01) -
Plasma YKL-40 is associated with prognosis in patients with metastatic pancreatic cancer receiving immune checkpoint inhibitors in combination with radiotherapy
by: Astrid Z. Johansen, et al.
Published: (2023-09-01)